MHC I级
抗原处理
内体
表位
细胞生物学
抗原
生物
CD8型
MHC II级
抗原呈递
T细胞
主要组织相容性复合体
MHC限制
效应器
细胞毒性T细胞
免疫系统
免疫学
体外
遗传学
细胞内
作者
Sebastian Kreiter,Abderraouf Selmi,Mustafa Diken,Martin Sebastian,Phillip Osterloh,Hansjörg Schild,Christoph Huber,Özlem Türeci,Uğur Şahin
出处
期刊:Journal of Immunology
[The American Association of Immunologists]
日期:2008-01-01
卷期号:180 (1): 309-318
被引量:162
标识
DOI:10.4049/jimmunol.180.1.309
摘要
Abstract Genetic modification of vaccines by linking the Ag to lysosomal or endosomal targeting signals has been used to route Ags into MHC class II processing compartments for improvement of CD4+ T cell responses. We report in this study that combining an N-terminal leader peptide with an MHC class I trafficking signal (MITD) attached to the C terminus of the Ag strongly improves the presentation of MHC class I and class II epitopes in human and murine dendritic cells (DCs). Such chimeric fusion proteins display a maturation state-dependent subcellular distribution pattern in immature and mature DCs, mimicking the dynamic trafficking properties of MHC molecules. T cell response analysis in vitro and in mice immunized with DCs transfected with Ag-encoding RNA showed that MITD fusion proteins have a profoundly higher stimulatory capacity than wild-type controls. This results in efficient expansion of Ag-specific CD8+ and CD4+ T cells and improved effector functions. We used CMVpp65 and NY-ESO-1 Ags to study preformed immune responses in CMV-seropositive individuals and cancer patients. We show that linking these Ags to the MITD trafficking signal allows simultaneous, polyepitopic expansion of CD8+ and CD4+ T cells, resulting in distinct CD8+ T cell specificities and a surprisingly broad and variable Ag-specific CD4+ repertoire in different individuals.
科研通智能强力驱动
Strongly Powered by AbleSci AI